Terns Pharmaceuticals, Inc.
TERN
Revenue
0.00
▼-1.00M▼-100.00%
12 Months ChangeAssets
378.23M
▲147.35M▲63.82%
3 Months ChangeLiabilities
13.76M
▲1.56M▲12.82%
3 Months ChangeFree Cash Flow
-22.83M
▼-8.45M▼-58.72%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-09-12
Form 8-K
ID: 0001193125-24-217444
2024-09-09
Form 8-K
ID: 0000950170-24-104550
2024-08-05
Form 10-Q
ID: 0000950170-24-090925
2024-08-05
Form 8-K
ID: 0000950170-24-090761
2024-07-29
Form 8-K
ID: 0000950170-24-087284
2024-07-03
Form 8-K
ID: 0000950170-24-081531
2024-06-12
Form 8-K
ID: 0000950170-24-072462
2024-05-13
Form 10-Q
ID: 0000950170-24-058672
2024-05-13
Form 8-K
ID: 0000950170-24-058209
2024-04-29
Form 8-K
ID: 0000950170-24-049870